Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. The Health Care sector as a whole closed the day up 0.8% versus the S&P 500, which was up 0.4%. Laggards within the Health Care sector included VirtualScopics ( VSCP), down 2.6%, Electromed ( ELMD), down 2.7%, SunLink Health Systems ( SSY), down 4.9%, Can Fite Biofarma ( CANF), down 3.8% and Semler Scientific ( SMLR), down 8.0%. TheStreet Ratings Group would like to highlight 3 stocks that pushed the sector lower today: Can Fite Biofarma ( CANF) is one of the companies that pushed the Health Care sector lower today. Can Fite Biofarma was down $0.16 (3.8%) to $4.15 on light volume. Throughout the day, 15,053 shares of Can Fite Biofarma exchanged hands as compared to its average daily volume of 21,200 shares. The stock ranged in price between $4.14-$4.32 after having opened the day at $4.32 as compared to the previous trading day's close of $4.32. Can Fite Biofarma has a market cap of $33.5 million and is part of the health services industry. Shares are down 28.9% year-to-date as of the close of trading on Friday. Currently there is 1 analyst who rates Can Fite Biofarma a buy, no analysts rate it a sell, and none rate it a hold. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Can-Fite BioPharma (CANF) stock is gaining on Monday afternoon as the company announced pre-clinical data for CF602, which demonstrated statistically significant full recovery from erectile dysfunction after a single dose.